Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EUK1001

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Agonists of M1 muscarinic acetylcholine receptors are promising therapeutic agents for the treatment of Alzheimer's disease (AD… Expand
Is this relevant?
2012
2012
The present study analyzed the influence of 3-[3-(3-florophenyl-2-propyn-1-ylthio)-1, 2, 5-thiadiazol-4-yl]-1, 2, 5, 6-tetrahydro… Expand
Is this relevant?
2011
2011
The M1/M4-preferring muscarinic agonist xanomeline was found to have some benefit in the treatment of the memory impairment of… Expand
Is this relevant?
2010
2010
The M1/M4 muscarinic acetylcholine receptor agonist xanomeline can significantly improve the cognitive function, but the… Expand
Is this relevant?
2008
2008
ObjectiveTo characterize the function of a new xanomeline-derived M1 agonist, 3-[3-(3-florophenyl-2-propyn-1-ylthio)-1,2,5… Expand
Is this relevant?
2008
2008
To characterize the function of a new xanomeline-derived M1 agonist, 3-[3-(3-florophenyl-2-propyn-1-ylthio)-1,2,5-thiadiazol-4-yl… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?